Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K041905
    Date Cleared
    2004-09-28

    (75 days)

    Product Code
    Regulation Number
    862.1150
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    HemosIL Calibration plasma is intended for the calibration of coagulation assays on IL and ELECTRA Coagulation Systems. The calibration plasma is prepared using citrated plasma plasmapheresed from healthy donors to maintain the characteristics of a normal plasma pool.

    Device Description

    HemosIL Calibration plasma is intended for the calibration of coagulation assays on IL and ELECTRA Coagulation Systems. The calibration plasma is prepared using citrated plasma plasmapheresed from healthy donors to maintain the characteristics of a normal plasma pool.

    AI/ML Overview

    Acceptance Criteria and Study for HemosIL Calibration Plasma

    This device, HemosIL Calibration Plasma, is a calibrator for coagulation assays. The performance data presented focuses on its precision in various coagulation analytes. Due to the nature of a calibrator, the acceptance criteria are implicitly tied to the precision requirements for each analyte as demonstrated by the predicate devices or established laboratory practice for calibration quality.

    Here's an analysis based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    The document does not explicitly state numerical acceptance criteria. However, typical acceptance criteria for calibrators revolve around established precision limits (e.g., %CV) that ensure the calibrator is stable and reliable for its intended use. The reported "Within Run %CV" values would be compared against these unstated, but generally understood, acceptable precision ranges for each analyte.

    AnalyteReagentReported MeanReported Within Run %CVImplicit Acceptance Criteria (Example)
    APTT (Seconds)HemosIL APTT-SP30.51.15e.g., < 5% CV
    Antithrombin (%)HemosIL Liquid Antithrombin1042.04e.g., < 5% CV
    Factor V (%)HemosIL FV Deficient Plasma1172.09e.g., < 5% CV
    Factor VIII (%)HemosIL FVIII Deficient Plasma83.24.28e.g., < 10% CV
    Fibrinogen - Clauss (mg/dL)HemosIL Fibrinogen-C2952.30e.g., < 5% CV
    Fibrinogen - PT-Based (mg/dL)HemosIL PT-Fib Recombinant2885.12e.g., < 10% CV
    Plasmin Inhibitor (%)HemosIL Plasmin Inhibitor97.72.02e.g., < 5% CV
    Plasminogen (%)HemosIL Plasminogen84.61.59e.g., < 5% CV
    Protein C (%)HemosIL ProClot96.84.73e.g., < 10% CV
    Protein S (%)HemosIL Protein S70.93.39e.g., < 5% CV
    PT (Seconds)HemosIL PT-Fib Recombinant11.01.45e.g., < 5% CV
    Thrombin Time (Seconds)HemosIL Thrombin Time (2 mL)7.591.84e.g., < 5% CV
    Thrombin Time (Seconds)HemosIL Thrombin Time (5 mL)16.92.13e.g., < 5% CV
    Thrombin Time (Seconds)HemosIL Thrombin Time (8 mL)24.51.27e.g., < 5% CV
    von Willebrand Factor (%)HemosIL VWF Antigen1041.13e.g., < 5% CV

    Note: The "Implicit Acceptance Criteria (Example)" column contains typical precision thresholds for similar analytes in laboratory settings, as the document does not explicitly state acceptance criteria. The reported performance shows all %CV values are well within typically accepted ranges for laboratory calibrators, indicating the device meets the implicit precision requirements.

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size: The precision testing involved running the HemosIL Calibration plasma in replicates of eight (n=8) for each analyte. This was performed across four ACL 9000 coagulation analyzers, resulting in a total of N=32 data points for each analyte (8 replicates * 4 analyzers).
    • Data Provenance: The document does not explicitly state the country of origin for the data or whether it was retrospective or prospective. However, given the context of a 510(k) submission to the FDA (USA) by a US-based company (Instrumentation Laboratory Company, Lexington, MA), it is highly probable that the study was conducted in the United States and was prospectively designed for the purpose of this submission.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

    This section is not applicable to this device. As a laboratory calibrator, its "ground truth" is not established by human expert consensus or interpretation of images/data. Instead, the "ground truth" for a calibrator refers to its assigned target values and the demonstration of its precision and consistency around those values. These values are determined through rigorous analytical methods and reference to primary standards or established methodologies, not expert opinions.

    4. Adjudication Method for the Test Set

    This section is not applicable to this device for the same reasons stated in point 3. Adjudication methods like 2+1 or 3+1 are used when human interpretation is involved and there's a need to resolve discrepancies. For a calibrator, the performance is assessed objectively through quantitative measurements of precision and accuracy against established analytical methods.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done

    No, an MRMC comparative effectiveness study was not done. This type of study is relevant for diagnostic devices that involve human interpretation (e.g., radiologists reading images) and assesses the impact of AI assistance on human performance. The HemosIL Calibration Plasma is a laboratory calibrator, not an AI-assisted diagnostic tool.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done

    This is implicitly analogous to standalone performance of the calibrator itself. The precision testing directly measures the performance of the calibrator (and the reagents/analyzers it calibrates) without human interpretation affecting the result. The study shows the inherent performance characteristics of the calibrator and its interaction with the coagulation systems and reagents.

    7. The Type of Ground Truth Used

    The "ground truth" for the HemosIL Calibration plasma is established through:

    • Analytical measurement: The reported "Mean" values for each analyte represent the established concentration or activity of that analyte in the calibrator plasma. These values are determined using highly accurate and precise laboratory methods.
    • Reference to established standards: While not explicitly detailed, calibrators like HemosIL are typically traceable to international reference materials or highly characterized primary standards to ensure accuracy and comparability across different laboratories.
    • Consistency and precision: The "Within Run %CV" demonstrates the calibrator's ability to consistently produce the same result when measured repeatedly, which is a critical aspect of its "truthfulness" as a calibrator.
    • Plasma source: The text mentions it's "prepared using citrated plasma plasmapheresed from healthy donors to maintain the characteristics of a normal plasma pool," which defines its biological "ground truth" as a normal human plasma matrix.

    8. The Sample Size for the Training Set

    This section is not applicable to this device. The HemosIL Calibration plasma is a biological product used for calibration; it is not an algorithm or AI model that requires a "training set" in the computational sense. Its "development" involves formulation, characterization, and value assignment, not machine learning.

    9. How the Ground Truth for the Training Set Was Established

    This section is not applicable for the same reasons explained in point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1